Dr. Jane Barlow is a clinical and strategic executive with over 25 years of healthcare leadership experience. She is EVP and Chief Clinical Officer for Real Endpoints, where she focuses on evaluating the economic impact and value of pharmaceuticals and diagnostics to aid in defining access, coverage, and contracting strategies with a focus on outcomes.

Dr. Barlow is Senior Advisor to the MIT Center for Biomedical Innovation New Drug Development Paradigms Initiative project on Financing of Curative Therapies in the US (FoCUS). As part of this initiative, she leverages her deep payer expertise to evaluate the impact of durable cell and gene therapies on payer financing and reimbursement strategies. The MIT NEWDIGS consortium FoCUS Project seeks to understand the financial challenges durable cell and gene therapies may create and generates solutions to promote sustainable patient access. This multi-stakeholder effort gathers input from over 150 individuals from over 50 organizations including patient advocacy groups, payers from all segments of the US healthcare system, manufacturers, ALKs, regulators, and academics working in healthcare policy, financing, and reimbursement.

Before joining RE, Dr. Barlow served as Associate Chief Medical Officer for CVS Health where she drove clinical strategies supporting drug purchasing, distribution, and utilization management for over 5B prescriptions yearly including over $40B in specialty revenue. In addition, she was Chief Medical Officer for the 11M life Medicare and government services business segment and served on the Board of Directors for SilverScript Insurance Company. Dr. Barlow has also held leadership roles Medco Health Solutions, IBM, the U.S. military, federal government, industry, and private practice.

Dr. Barlow attended medical school at Creighton University and completed her residency training in occupational medicine at Johns Hopkins University. She holds masters’ degrees in business administration and public health and is a Certified Physician Executive with a certificate in Health Information Technology from the American Association of Physician Leaders. Dr. Barlow is board-certified in occupational medicine and is a fellow of both the American College of Occupational and Environmental Medicine and the American College of Preventive Medicine. She serves on the board of directors of Momenta Pharmaceuticals, Inc. and the advisory board for Pictet Asset Management. She previously served on the board of TherapeuticsMD.